Basiliximab for IL-2-Associated Inflammatory Disorder With Atopic Dermatitis.

Summary: A 10-year-old boy suffered from severe, unmanageable eczema (atopic dermatitis) accompanied by mysterious fevers and joint pain. Standard biological treatments failed to help him. Doctors identified a specific immune system marker—elevated IL-2 receptors—driving his inflammation. By repurposing Basiliximab, a drug typically used to prevent organ transplant rejection, they successfully treated his condition. This case suggests that targeting specific immune signals can provide relief for difficult-to-treat skin disorders when standard therapies fail.